16.04.2015 Views

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

ANNUAL REPORT 2012 - TiGenix

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Remuneration of the audit committee in <strong>2012</strong><br />

In <strong>2012</strong>, the following amounts were accrued for fees of the independent directors as member of<br />

the audit committee for the performance of their mandate during the financial year <strong>2012</strong> :<br />

Name Name Fee<br />

Willy Duron<br />

Chairman of the audit committee;<br />

7,500<br />

Independent Director<br />

Eduard Enrico Holdener (1)<br />

Member of the audit committee;<br />

3,750<br />

Independent Director<br />

Innosté SA, represented by Jean Stéphenne (2) Member of the audit committee;<br />

1,250<br />

Chairman of the Board of Directors;<br />

Independent Director<br />

LRM Beheer NV, represented<br />

Member of the audit committee;<br />

-<br />

by Nico Vandervelpen<br />

Director (non-executive)<br />

TOTAL 12,500<br />

(1)<br />

Eduardo Enrico Holdener was a member of the audit committee until September 19, <strong>2012</strong>.<br />

(2)<br />

Innosté SA, represented by Jean Stéphenne, has been a member of the audit committee since September 19, <strong>2012</strong>.<br />

Remuneration of the nomination and remuneration committee in <strong>2012</strong><br />

In <strong>2012</strong>, the following amounts were accrued for fees of the independent directors as member of<br />

the nomination and remuneration committee for the performance of their mandate during the<br />

financial year <strong>2012</strong> :<br />

Name Name Fee<br />

R&S Consulting BVBA, represented by Dirk Reyn (1) Chairman of the nomination<br />

11,625<br />

and remuneration committee;<br />

Independent Director<br />

Greig Biotechnology Global Consulting, Inc., Member of the nomination<br />

1,250<br />

represented by Russell G. Greig (2)<br />

and remuneration committee;<br />

Independent Director<br />

Eduard Enrico Holdener (3)<br />

Member of the nomination<br />

and remuneration committee;<br />

Independent Director<br />

12,875<br />

Ysios Capital Partners SGECR SA, represented by<br />

Joël Jean-Mairet (4)<br />

Member of the nomination and<br />

remuneration committee; Director<br />

(non-executive)<br />

TOTAL 25,750<br />

(1)<br />

R&S <br />

Consulting BVBA, represented by Dirk Reyn, was appointed Chairman of the nomination and remuneration committee as of<br />

September 19, <strong>2012</strong>.<br />

(2)<br />

Greig Biotechnology Global Consulting, Inc., represented by Russell G. Greig, has been a member of the nomination and<br />

remuneration committee since September 19, <strong>2012</strong>.<br />

(3)<br />

Eduard Enrico Holdener was Chairman of the nomination and remuneration committee until September 19, <strong>2012</strong>.<br />

(4)<br />

Ysios Capital Partners SGECR SA, represented by Joël Jean-Mairet, was a member of the nomination and remuneration<br />

committee until September 19, <strong>2012</strong>.<br />

-<br />

186 <strong>TiGenix</strong> I annual report <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!